← TrialMatch
HomeTrials

High Resolution Diffusion Weighted Imaging in Prostate

hrDWI might be an alternative to cDWI for the prostate imaging. 1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general 2. improve the diagnostic accuracy of PCa in particular than conventional DWI

Condition(s)Prostate Cancer, Prostate Disease
StatusRecruiting
Study typeObservational
SummaryhrDWI might be an alternative to cDWI for the prostate imaging. 1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general 2. improve the diagnostic accuracy of PCa in particular than conventional DWI
Who can participateInclusion Criteria: 1. Patients who underwent standard MR scanning including T2WI, cDWI , hrDWI and respective calculated apparent diffusion coefficient (ADC) maps; 2. Complete clinical information. Exclusion Criteria: Men were excluded if they were using 5-alpha-reductase inhibitors at time of examination or has used such during the previous six months; or if they had a previous history of prostatic biopsy, prostatic surgery, or treatment for PCa
Ages55 Years
SexMale
Lead sponsorThe First Affiliated Hospital with Nanjing Medical University
LocationsNanjing, Jiangsu, China; Nanjing, China
Start date2023-08-01
NCT IDNCT06636747
Official listinghttps://clinicaltrials.gov/study/NCT06636747

🔍 Search all trials →